Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating depression with atypical features.

Jonathan W Stewart1

  • 1Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA. jws6@columbia.edu

The Journal of Clinical Psychiatry
|March 14, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Effect of age on the response to serotonergic and noradrenergic antidepressants: A systematic review, meta-regression and individual participant data pooled analysis" [J. Psychiatr. Res. 183 (2025) 133-143 doi. 10.1016/j.jpsychires.2025.02.013].

Journal of psychiatric research·2025
Same author

Effect of age on the response to serotonergic and noradrenergic antidepressants: A systematic review, meta-regression and individual participant data pooled analysis.

Journal of psychiatric research·2025
Same author

Serotonin-norepinephrine reuptake inhibitor antidepressant effects on regional connectivity of the thalamus in persistent depressive disorder: evidence from two randomized, double-blind, placebo-controlled clinical trials.

Brain communications·2022
Same author

A randomized, controlled trial assessing the acute efficacy of triple chronotherapy in unipolar depression.

Journal of affective disorders·2021
Same author

Gray matter reorganization underpinnings of antidepressant treatment of persistent depressive disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2021
Same author

Treatment of Maternal Depression in a Medication Clinical Trial and Its Effect on Children.

Focus (American Psychiatric Publishing)·2020

Monoamine oxidase inhibitors (MAOIs) like phenelzine are effective for atypical depression but have side effects. Newer treatments show promise, but older drugs remain the most effective.

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Atypical depression presents unique challenges in treatment compared to melancholic depression.
  • Early recognition linked atypical depression to specific responses to monoamine oxidase inhibitors (MAOIs).

Observation:

  • Phenelzine, an MAOI, demonstrated high response rates in atypical depression but has safety concerns.
  • Research explored tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), chromium, and cognitive therapy for improved safety and efficacy.

Findings:

  • TCAs were less effective than MAOIs and had significant side effects.
  • SSRIs show potential, but direct comparative studies are lacking for definitive conclusions.
  • Cognitive therapies show promise but require more comparative research against MAOIs and placebo.

Related Experiment Videos

Implications:

  • Despite advancements, effective treatment for atypical depression still relies on established, albeit older, medications.
  • Further research is needed to establish the efficacy and safety of newer agents and therapies for atypical depression.